Prevalence of colistin heteroresistance in carbapenem-resistant Pseudomonas aeruginosa and association with clinical outcomes in patients: an observational study.
Jessica R Howard-AndersonMichelle DavisAlexander M PageChris W BowerGillian SmithJesse T JacobDan I AnderssonDavid S WeissSarah W SatolaPublished in: The Journal of antimicrobial chemotherapy (2022)
Colistin heteroresistance was identified in up to 26% of patients with CRPA in our sample, although the prevalence varied depending on the definition. We did not observe an apparent association between colistin heteroresistance and 90 day mortality.
Keyphrases
- pseudomonas aeruginosa
- acinetobacter baumannii
- escherichia coli
- klebsiella pneumoniae
- risk factors
- multidrug resistant
- cystic fibrosis
- drug resistant
- end stage renal disease
- gram negative
- biofilm formation
- chronic kidney disease
- ejection fraction
- newly diagnosed
- prognostic factors
- magnetic resonance imaging
- type diabetes
- computed tomography
- coronary artery disease